280 related articles for article (PubMed ID: 19184538)
21. Autotaxin regulates vascular development via multiple lysophosphatidic acid (LPA) receptors in zebrafish.
Yukiura H; Hama K; Nakanaga K; Tanaka M; Asaoka Y; Okudaira S; Arima N; Inoue A; Hashimoto T; Arai H; Kawahara A; Nishina H; Aoki J
J Biol Chem; 2011 Dec; 286(51):43972-43983. PubMed ID: 21971049
[TBL] [Abstract][Full Text] [Related]
22. Exosomes bind to autotaxin and act as a physiological delivery mechanism to stimulate LPA receptor signalling in cells.
Jethwa SA; Leah EJ; Zhang Q; Bright NA; Oxley D; Bootman MD; Rudge SA; Wakelam MJ
J Cell Sci; 2016 Oct; 129(20):3948-3957. PubMed ID: 27557622
[TBL] [Abstract][Full Text] [Related]
23. Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8
Matas-Rico E; Frijlink E; van der Haar Àvila I; Menegakis A; van Zon M; Morris AJ; Koster J; Salgado-Polo F; de Kivit S; Lança T; Mazzocca A; Johnson Z; Haanen J; Schumacher TN; Perrakis A; Verbrugge I; van den Berg JH; Borst J; Moolenaar WH
Cell Rep; 2021 Nov; 37(7):110013. PubMed ID: 34788605
[TBL] [Abstract][Full Text] [Related]
24. Autotaxin-lysophosphatidic acid-LPA
Aikawa S; Kano K; Inoue A; Wang J; Saigusa D; Nagamatsu T; Hirota Y; Fujii T; Tsuchiya S; Taketomi Y; Sugimoto Y; Murakami M; Arita M; Kurano M; Ikeda H; Yatomi Y; Chun J; Aoki J
EMBO J; 2017 Jul; 36(14):2146-2160. PubMed ID: 28588064
[TBL] [Abstract][Full Text] [Related]
25. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.
Budd DC; Qian Y
Future Med Chem; 2013 Oct; 5(16):1935-52. PubMed ID: 24175745
[TBL] [Abstract][Full Text] [Related]
26. Autotaxin determines colitis severity in mice and is secreted by B cells in the colon.
Lin S; Haque A; Raeman R; Guo L; He P; Denning TL; El-Rayes B; Moolenaar WH; Yun CC
FASEB J; 2019 Mar; 33(3):3623-3635. PubMed ID: 30481488
[TBL] [Abstract][Full Text] [Related]
27. Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways.
Zhao J; He D; Berdyshev E; Zhong M; Salgia R; Morris AJ; Smyth SS; Natarajan V; Zhao Y
Biochem J; 2011 Oct; 439(1):45-55. PubMed ID: 21696367
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of autotaxin by bile salts and bile salt-like molecules increases its expression by feedback regulation.
Langedijk JAGM; Tolenaars D; Bolier R; Lee YT; Meurs A; Williamson C; Adorini L; van de Graaf SFJ; Beuers U; Elferink RO
Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166239. PubMed ID: 34389475
[TBL] [Abstract][Full Text] [Related]
29. Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease.
Jose A; Kienesberger PC
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502491
[TBL] [Abstract][Full Text] [Related]
30. Autotaxin/Lpar3 signaling regulates Kupffer's vesicle formation and left-right asymmetry in zebrafish.
Lai SL; Yao WL; Tsao KC; Houben AJ; Albers HM; Ovaa H; Moolenaar WH; Lee SJ
Development; 2012 Dec; 139(23):4439-48. PubMed ID: 23095890
[TBL] [Abstract][Full Text] [Related]
31. Chronic rhinosinusitis with nasal polyps and without nasal polyps is associated with increased expression of lysophosphatidic acid-related molecules.
Park SJ; Jun YJ; Lee KJ; Hwang SM; Kim TH; Lee SH; Lee SH
Am J Rhinol Allergy; 2014; 28(3):199-207. PubMed ID: 24980231
[TBL] [Abstract][Full Text] [Related]
32. Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling.
Keune WJ; Hausmann J; Bolier R; Tolenaars D; Kremer A; Heidebrecht T; Joosten RP; Sunkara M; Morris AJ; Matas-Rico E; Moolenaar WH; Oude Elferink RP; Perrakis A
Nat Commun; 2016 Apr; 7():11248. PubMed ID: 27075612
[TBL] [Abstract][Full Text] [Related]
33. Targeting the autotaxin - Lysophosphatidic acid receptor axis in cardiovascular diseases.
Zhao Y; Hasse S; Zhao C; Bourgoin SG
Biochem Pharmacol; 2019 Jun; 164():74-81. PubMed ID: 30928673
[TBL] [Abstract][Full Text] [Related]
34. Loss of FOXF1 expression promotes human lung-resident mesenchymal stromal cell migration via ATX/LPA/LPA1 signaling axis.
Cao P; Walker NM; Braeuer RR; Mazzoni-Putman S; Aoki Y; Misumi K; Wheeler DS; Vittal R; Lama VN
Sci Rep; 2020 Dec; 10(1):21231. PubMed ID: 33277571
[TBL] [Abstract][Full Text] [Related]
35. [Function and biological activities of the autotaxin-LPA axis].
Li ZW; Zhao YR; Zhao C; Fu R; Li ZY
Sheng Li Xue Bao; 2011 Dec; 63(6):601-10. PubMed ID: 22193457
[TBL] [Abstract][Full Text] [Related]
36. Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
Panupinthu N; Lee HY; Mills GB
Br J Cancer; 2010 Mar; 102(6):941-6. PubMed ID: 20234370
[TBL] [Abstract][Full Text] [Related]
37. Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency.
Salgado-Polo F; Fish A; Matsoukas MT; Heidebrecht T; Keune WJ; Perrakis A
J Biol Chem; 2018 Sep; 293(37):14312-14327. PubMed ID: 30026231
[TBL] [Abstract][Full Text] [Related]
38. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
Black KE; Berdyshev E; Bain G; Castelino FV; Shea BS; Probst CK; Fontaine BA; Bronova I; Goulet L; Lagares D; Ahluwalia N; Knipe RS; Natarajan V; Tager AM
FASEB J; 2016 Jun; 30(6):2435-50. PubMed ID: 27006447
[TBL] [Abstract][Full Text] [Related]
39. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
Magkrioti C; Oikonomou N; Kaffe E; Mouratis MA; Xylourgidis N; Barbayianni I; Megadoukas P; Harokopos V; Valavanis C; Chun J; Kosma A; Stathopoulos GT; Bouros E; Bouros D; Syrigos K; Aidinis V
Cancer Res; 2018 Jul; 78(13):3634-3644. PubMed ID: 29724718
[TBL] [Abstract][Full Text] [Related]
40. The Expression Regulation and Biological Function of Autotaxin.
Zhang X; Li M; Yin N; Zhang J
Cells; 2021 Apr; 10(4):. PubMed ID: 33921676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]